These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 17913666)

  • 1. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiplexed analysis for identification and evaluation of novel biomarkers in biological fluids, tissue and cell extracts].
    Lehmann S; Dupuy A; Beaudeux JL; Lizard G
    Ann Biol Clin (Paris); 2009; 67(4):381-93. PubMed ID: 19654078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF; Haab BB; Hanash SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New frontiers in proteomics research: a perspective.
    Dhingra V; Gupta M; Andacht T; Fu ZF
    Int J Pharm; 2005 Aug; 299(1-2):1-18. PubMed ID: 15979831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology insight: the application of proteomics in gastrointestinal disease.
    Din S; Lennon AM; Arnott ID; Hupp T; Satsangi J
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):372-85. PubMed ID: 17607293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis of human cerebrospinal fluid.
    Yuan X; Desiderio DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic chips for mass spectrometry-based proteomics.
    Lee J; Soper SA; Murray KK
    J Mass Spectrom; 2009 May; 44(5):579-93. PubMed ID: 19373851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of proteomic techniques to fungal protein identification and quantification.
    Rohrbough JG; Galgiani JN; Wysocki VH
    Ann N Y Acad Sci; 2007 Sep; 1111():133-46. PubMed ID: 17344531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular scanner: concept and developments.
    Binz PA; Müller M; Hoogland C; Zimmermann C; Pasquarello C; Corthals G; Sanchez JC; Hochstrasser DF; Appel RD
    Curr Opin Biotechnol; 2004 Feb; 15(1):17-23. PubMed ID: 15102461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
    Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A streamlined approach to high-throughput proteomics.
    Stephens AN; Quach P; Harry EJ
    Expert Rev Proteomics; 2005 Apr; 2(2):173-85. PubMed ID: 15892563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction into proteomics and its clinical applications.
    Ahram M
    Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics technology.
    Dominguez DC; Lopes R; Torres ML
    Clin Lab Sci; 2007; 20(4):239-44. PubMed ID: 18069450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics and the haematologist.
    Rees-Unwin KS; Morgan GJ; Davies FE
    Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.